Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials

-100% protection against severe disease
-Final analysis in U.K. trial confirms 96% efficacy against original strain of COVID-19
-Efficacy against variants confirmed in U.K. and South Africa